A researcher and provider of ketamine-assisted treatments for mental health conditions, Braxia Scientific Corp. (OTC:BRAXF) has completed the acquisition of the issued and outstanding stock of U.S.-based, private telemedicine company KetaMD Inc., with the goal of addressing mental health issues by providing access to technology-mediated ketamine treatments.
Founded by psychedelic pioneers Zappy Zapolin and Warren Gumpel along with mindfulness instructor Kaia Roman and president and COO Leann Taylor, KetaMD's telemedicine platform works to provide access to safe and affordable at-home ketamine treatments for those suffering from depression and related mental health conditions across the country.
